Clinic for Cardiology and Pneumology, University Medical Center, 37075 Göttingen, Germany.
DZHK (German Center for Cardiovascular Research), Partner Site Göttingen and Rhein Main, 61231 Bad Nauheim, Germany.
Int J Mol Sci. 2023 Jun 15;24(12):10189. doi: 10.3390/ijms241210189.
In heart failure and atrial fibrillation, a persistent Na current (I) exerts detrimental effects on cellular electrophysiology and can induce arrhythmias. We have recently shown that Na1.8 contributes to arrhythmogenesis by inducing a I. Genome-wide association studies indicate that mutations in the gene (Na1.8) are associated with increased risk for arrhythmias, Brugada syndrome, and sudden cardiac death. However, the mediation of these Na1.8-related effects, whether through cardiac ganglia or cardiomyocytes, is still a subject of controversial discussion. We used CRISPR/Cas9 technology to generate homozygous atrial -KO-iPSC-CMs. Ruptured-patch whole-cell patch-clamp was used to measure the I and action potential duration. Ca measurements (Fluo 4-AM) were performed to analyze proarrhythmogenic diastolic SR Ca leak. The I was significantly reduced in atrial KO CMs as well as after specific pharmacological inhibition of Na1.8. No effects on atrial APD were detected in any groups. Both KO and specific blockers of Na1.8 led to decreased Ca spark frequency and a significant reduction of arrhythmogenic Ca waves. Our experiments demonstrate that Na1.8 contributes to I formation in human atrial CMs and that Na1.8 inhibition modulates proarrhythmogenic triggers in human atrial CMs and therefore Na1.8 could be a new target for antiarrhythmic strategies.
在心力衰竭和心房颤动中,持续的钠离子电流 (I) 对细胞电生理产生有害影响,并可引发心律失常。我们最近表明,Na1.8 通过诱导 I 来引发心律失常。全基因组关联研究表明, 基因 (Na1.8) 的突变与心律失常、Brugada 综合征和心脏性猝死的风险增加有关。然而,这些与 Na1.8 相关的影响的介导,无论是通过心脏神经节还是心肌细胞,仍然是一个有争议的讨论主题。我们使用 CRISPR/Cas9 技术生成纯合的心房 -KO-iPSC-CMs。使用破裂贴片全细胞贴片钳测量 I 和动作电位持续时间。通过 Ca 测量(Fluo 4-AM)分析促心律失常性舒张 SR Ca 渗漏。在心房 -KO-CMs 中以及在 Na1.8 的特异性药理学抑制后,I 明显降低。在任何组中都未检测到心房 APD 的影响。-KO 和 Na1.8 的特异性阻断剂均导致 Ca 火花频率降低和致心律失常性 Ca 波明显减少。我们的实验表明,Na1.8 有助于人类心房心肌细胞中 I 的形成,并且 Na1.8 抑制调节人类心房心肌细胞中的致心律失常触发因素,因此 Na1.8 可能成为抗心律失常策略的新靶点。